Cargando…
Antipsychotic-induced bone loss: the role of dopamine, serotonin and adrenergic receptor signalling
Antipsychotics are commonly used in treating psychiatric disorders. These medications primarily target dopamine the serotonin receptors, they have some affinity to adrenergic, histamine, glutamate and muscarinic receptors. There is clinical evidence that antipsychotic use decreases BMD and increases...
Autores principales: | Weerasinghe, D. Kavindi, Hodge, Jason M., Pasco, Julie A., Samarasinghe, Rasika M., Azimi Manavi, Behnaz, Williams, Lana J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248006/ https://www.ncbi.nlm.nih.gov/pubmed/37305679 http://dx.doi.org/10.3389/fcell.2023.1184550 |
Ejemplares similares
-
Antipsychotic medication use and fracture: a case–control study
por: Azimi Manavi, Behnaz, et al.
Publicado: (2023) -
Use of antipsychotic medication and its relationship with bone mineral density: A population-based study of men and women
por: Azimi Manavi, Behnaz, et al.
Publicado: (2023) -
Antipsychotic medication use in association with quantitative heel ultrasound (QUS)
por: Azimi Manavi, Behnaz, et al.
Publicado: (2023) -
Biofabrication of functional bone tissue: defining tissue-engineered scaffolds from nature
por: Rifai, Aaqil, et al.
Publicado: (2023) -
Study protocol for the systematic review and meta-analyses of the association between schizophrenia and bone fragility
por: Azimi Manavi, Behnaz, et al.
Publicado: (2020)